<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03120702</url>
  </required_header>
  <id_info>
    <org_study_id>CHOC0002</org_study_id>
    <nct_id>NCT03120702</nct_id>
  </id_info>
  <brief_title>Measurement of Total Hemoglobin by Pulse Oximetry in Neonatal Population</brief_title>
  <official_title>Measurement of Total Hemoglobin by Pulse Oximetry in Neonatal Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masimo Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Masimo Corporation</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assess ability of Masimo SpHb sensor to demonstrate robust performance on various sensor&#xD;
      application sites on neonates/infants&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 23, 2013</start_date>
  <completion_date type="Actual">April 20, 2017</completion_date>
  <primary_completion_date type="Actual">April 20, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assess ability of Masimo SpHb sensor to demonstrate robust performance on various sensor application sites on neonates/infants</measure>
    <time_frame>duration of surgery</time_frame>
    <description>To study the SpHb sensor in neonatal population.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">128</enrollment>
  <condition>Anemia</condition>
  <arm_group>
    <arm_group_label>Neonatal Test Subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All test subjects in this group are neonatal patients who will receive a investigational Rainbow SpHb sensor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Investigational Rainbow SpHb sensor</intervention_name>
    <description>Investigational Rainbow SpHb sensor</description>
    <arm_group_label>Neonatal Test Subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female newborn infants of any gestational age requiring at least one (1) blood&#xD;
             draw as part of their routine care.&#xD;
&#xD;
          -  Ages: Newborn infants less than 16 weeks postnatal age.&#xD;
&#xD;
          -  Weight: Range from 500 g to 10 kg.&#xD;
&#xD;
          -  Able to obtain written informed consent from parents or legal guardians&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Neonatal patients with abnormalities at the planned application sites that would&#xD;
             interfere with transilluminating the foot or hand like unusual deformities of limbs,&#xD;
             absence of feet, severe edema, localized infections, and other.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>16 Weeks</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Children's Hospital of Orange County</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 14, 2017</study_first_submitted>
  <study_first_submitted_qc>April 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2017</study_first_posted>
  <disposition_first_submitted>May 31, 2018</disposition_first_submitted>
  <disposition_first_submitted_qc>May 31, 2018</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">April 28, 2021</disposition_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

